Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes

American Heart Journal

Volumn 151, Issue 6, 2006, Pages 1247.e1-1247.e7

  Lee, Duk Hee ^a   Zacharski, Leo R ^b,c   Jacobs Jr , David R ^d,e  

^a Kyungpook National University School of Medicine   (South Korea)

^b VA MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; IRON; TRANSFERRIN; VITAMIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEALTH SURVEY; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; METABOLISM;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HUMANS; IRON; MALE; OXIDATIVE STRESS; TRANSFERRIN; VITAMINS;

EID: 33746206425     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.03.009     Document Type: Article

References (41)

1. Mayne S.T. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr 133 Suppl 3 (2003) 933S-940S
2. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 25 (1996) 57-74
3. McCord J.M. Iron, free radicals, and oxidative injury. Semin Hematol 35 (1998) 5-12
4. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic Biol 23 (1997) 783-792
5. Sullivan J.L. Stored iron and vascular reactivity. Arterioscler Thromb Vasc Biol 25 (2005) 1532-1535
6. Ma J., and Stampfer M.J. Body iron stores and coronary heart disease. Clin Chem 48 (2002) 601-603
7. Danesh J., and Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 99 (1999) 852-854
8. Nelson R.L. Iron and colorectal cancer risk: human studies. Nutr Rev 59 (2001) 140-148
9. Sempos C.T. Iron and colorectal cancer. Nutr Rev 59 (2001) 344-346
10. Lee D.H., and Jacobs Jr. D. Serum markers of stored body iron are not appropriate markers of health effects of iron: a focus on serum ferritin. Med Hypotheses 62 (2004) 442-445
11. Pleiner J., Mittermayer F., Schaller G., et al. Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. J Am Coll Cardiol 42 (2003) 1656-1662
12. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429 (2001) 195-207
13. Rahman I., and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16 (2000) 534-554
14. Cook J.D., Lipschitz D.A., Miles L.E., et al. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 27 (1974) 681-687
15. Bassett M.L., Halliday J.W., Ferris R.A., et al. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology 87 (1984) 628-633
16. Valberg L.S., Ghent C.N., Lloyd D.A., et al. Diagnostic efficacy of tests for the detection of iron overload in chronic liver disease. Can Med Assoc J 119 (1978) 229-236
17. National Center for Health Statistics, US Department of Health and Human Services. Third National Health and Nutrition Examination Survey, 1988-1994. Reference manuals and reports (CD-ROM) (1996), Centers for Disease Control and Prevention, Hyattsville (Md)
18. Gross M., Yu X., Hannan P., et al. Lipid standardization of serum fat-soluble antioxidant concentrations: the YALTA Study. Am J Clin Nutr 77 (2003) 458-466
19. You S.A., and Wang Q. Ferritin in atherosclerosis. Clin Chim Acta 357 (2005) 1-16
20. Zacharski L.R., Ornstein D.L., Woloshin S., et al. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 140 (2000) 98-104
21. Pietrangelo A. Iron, friend or foe? "Freedom" makes the difference. J Hepatol 32 (2000) 862-864
22. Ponka P., Beaumont C., and Richardson D.R. Function and regulation of transferrin and ferritin. Semin Hematol 35 (1998) 35-54
23. Zheng H., Cable R., Spencer B., et al. Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol 25 (2005) 1577-1583
24. Nakano M., Kawanishi Y., Kamohara S., et al. Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: a study on 2507 healthy people. Free Radic Biol Med 35 (2003) 826-832
25. Zacharski L.R., Chow B.K., Howes P.S., et al. Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST). Am Heart J 148 (2004) 386-392
26. Witte D.L. Can serum ferritin be effectively interpreted in the presence of the acute-phase response?. Clin Chem 37 (1991) 484-485
27. Poznanovic G., Petrovic M., and Magic Z. Re-establishment of homeostasis and the acute-phase proteins. Panminerva Med 39 (1997) 291-298
28. Biemond P., van Eijk H.G., Swaak A.J., et al. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J Clin Invest 73 (1984) 1576-1579
29. Reif D.W., and Simmons R.D. Nitric oxide mediates iron release from ferritin. Arch Biochem Biophys 283 (1990) 537-541
30. Orino K., Lehman L., Tsuji Y., et al. Ferritin and the response to oxidative stress. Biochem J 357 (2001) 241-247
31. Balla G., Jacob H.S., Balla J., et al. Ferritin: a cytoprotective antioxidant stratagem of endothelium. J Biol Chem 267 (1992) 18148-18153
32. Cairo G., Tacchini L., Pogliaghi G., et al. Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J Biol Chem 270 (1995) 700-703
33. Loreal O., Gosriwatana I., Guyader D., et al. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol 32 (2000) 727-733
34. Kakhlon O., and Cabantchik Z.I. The labile iron pool: characterization, measurement, and participation in cellular processes (1). Free Radic Biol Med 33 (2002) 1037-1046
35. Breuer W., Hershko C., and Cabantchik Z.I. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 23 (2000) 185-192
36. De Feo T.M., Fargion S., Duca L., et al. Non-transferrin-bound iron in alcohol abusers. Alcohol Clin Exp Res 25 (2001) 1494-1499
37. Fletcher L.M., Halliday J.W., and Powell L.W. Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin. J Gastroenterol and Hepatol 14 (1999) 202-214
38. Lee D.H., Anderson K.E., Harnack L.J., et al. Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study. JNCI 96 (2004) 403-407
39. Lee D.H., Folsom A.R., and Jacobs Jr. D.R. Dietary iron intake and type 2 diabetes incidence in postmenopausal women: the Iowa Women's Health Study. Diabetologia 47 (2004) 185-194
40. Lee D.H., Folsom A.R., and Jacobs Jr. D.R. Iron, zinc, alcohol consumption, and mortality from cardiovascular diseases: Iowa Women's Health Study. Am J Clin Nutr 81 (2005) 787-791
41. Lee D.H., Anderson K.E., Folsom A.R., et al. Heme iron, zinc and upper digestive tract cancer: the Iowa Women's Health Study. Int J Cancer 117 (2005) 643-647